Video: TL1 Trainee Kathryn McElhinney Explores Development of Bioprosthetic Ovary
Kathryn McElhinney, MD, specializes in reducing infertility risks in adolescent chemotherapy treatments, an often overlooked quality of life indicator. The NUCATS Institute’s TL1 program encourages this pediatric exploration at the intersection of research and clinical application. Watch video
The opportunities here with the fertility and hormone preservation and restoration program was just a unique option. The fact that it really does have an emphasis on translational research and on children, it pretty much encapsulated everything we were going for.”
Research reported in this publication was supported, in part, by the National Institutes of Health's National Center for Advancing Translational Sciences, Grant Number TL1TR001423. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
